n-(1-methyl-2-phenylethyl)adenosine and carbachol
n-(1-methyl-2-phenylethyl)adenosine has been researched along with carbachol in 4 studies
Compound Research Comparison
| Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (carbachol) | Trials (carbachol) | Recent Studies (post-2010) (carbachol) |
|---|---|---|---|---|---|
| 134 | 0 | 4 | 13,918 | 81 | 968 |
Protein Interaction Comparison
| Protein | Taxonomy | n-(1-methyl-2-phenylethyl)adenosine (IC50) | carbachol (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.7849 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 2.0626 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 3.4134 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 2.9961 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 2.535 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 2.9961 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 2.6638 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.849 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 4.99 |
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Mainra, RR; Sulakhe, PV; Vo, XT | 1 |
| Cohen, MV; Downey, JM; Hashimi, MW; Thornton, JD | 1 |
| el-Ani, D; Jacobson, KA; Katz, A; Shainberg, A; Zimlichman, R | 1 |
| Akera, T; Chugun, A; Hara, Y; Kennedy, RH; Klimberg, SV; Sasaki, T; Temma, K; Uchide, T | 1 |
Other Studies
4 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and carbachol
| Article | Year |
|---|---|
Differential nature of cross-talk among three G-coupled receptors regulating adenylyl cyclase in rat cardiomyocytes chronically exposed to receptor agonists.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Carbachol; Cell Culture Techniques; Enzyme Activation; GTP-Binding Proteins; Isoproterenol; Muscarinic Agonists; Myocardium; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Muscarinic; Receptors, Purinergic P1; Vasodilator Agents | 1997 |
Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(-)-N6-(2-phenylisopropyl)adenosine is related to defect at the adenosine A1 receptor.
Topics: Adenosine; Animals; Carbachol; Down-Regulation; Female; GTP-Binding Proteins; Hemodynamics; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Protein Kinase C; Rabbits; Receptors, Purinergic P1 | 1998 |
Uptake of glucose analogs reflects the rate of contraction of cultured myocytes.
Topics: 3-O-Methylglucose; Adenosine; Animals; Animals, Newborn; Carbachol; Cardiotonic Agents; Cells, Cultured; Deoxyglucose; Dipyridamole; Dose-Response Relationship, Drug; Glucose; Isoproterenol; Kinetics; Myocardial Contraction; Myocardium; Rats; Temperature; Time Factors; Vasodilator Agents | 1999 |
Doxorubicin affects the cardiac muscarinic system in the rat.
Topics: Adenosine; Animals; Antineoplastic Agents; Binding, Competitive; Carbachol; Cardiotonic Agents; Depression, Chemical; Doxorubicin; Drug Interactions; Heart; In Vitro Techniques; Muscarinic Antagonists; Myocardial Contraction; Purinergic P1 Receptor Agonists; Quinuclidinyl Benzilate; Rats; Receptors, Muscarinic; Vasodilator Agents | 2001 |